content top

X Linked Retinoschisis and RD Pre- and Post-operatively

              Color image of an X linked retinoschisis and detachment pre and postoperatively. Contact Details: Email: parolinibarbara@gmail.com Cell Phone:...

Read More

Macular Surgery in Retinitis Pigmentosa Agnieszka Nowosielska

Retinitis pigmentosa is devastating disorder which leads to poor vision. Usually central vision is relativelly spared for longer time. However RP patients may suffer from macular problems (CMO, MH, ERM, pseudoholes) which additionally destroy the island of vision which is left. In disorders mentioned above, in otherwise healthy eyes, there would be not doubts if one should perform surgery. But what should be done RP case with in macular...

Read More

Relationship Between Color Vision Deficiency & Foveal Anatomical Changes in Retinitis Pigmentosa

Pamela Campos Figueroa_SCIENTIFIC POSTER 2015 Background: Retinitis pigmentosa (RP) is an inherited disease characterized by photoreceptors and retinal pigment epithelium degeneration. The peripheral vision in patients with RP is highly compromised and the remaining central vision is associated with functional vision, and is commonly used to monitor disease development. As the disease progresses, patients undergo loss of visual acuity and...

Read More

Severe Retinitis Pigmentosa of Early Onset in a Previously Diagnosed Amblyopia: Case Report

SCIENTIFIC POSTER_Carolina Vale_2 Background: Retinitis pigmentosa (RP) is a group of hereditary disorders that diffusely involve photoreceptors and pigmental epithelial function with a prevalence of about 1:5000. All inheritance patterns are described and more than 45 genes causing RP have been reported that might explain the heterogenicity of clinical presentation. The majority of RP cases occurs isolated with disease process confined to...

Read More

Can Retinitis Pigmentosa Influence MH Surgical Results?

Poster 2 Joaquin Castro Navarro Advantages: To report a case of unilateral recurrent macular hole in a patient affected by retinitis pigmentosa (RP). Methods: A 64-year-old woman, with the previous diagnosis of RP, was referred to our department with a complaint of central visual loss in her left eye (LE) for 12 months. A complete ocular exploration, including determination of Best Corrected Visual Acuity (BCVA) (decimal notation),...

Read More

Management of ME in Retinitis Pigmentosa with Topical Dorzolamide

Advantages: Retinitis pigmentosa may be associated with macular edema and cystoid spaces. Topical dorzolamide may be useful in improving macular edema. Methods: Prospective evaluation of the use of dorzolamiteĀ  (topical 3 times daily for 3-6 months) in ME cases associated with RP. Six cases with RP were identified by OCTas having macular edema. A course of dorzolamide drops was initiated 3 times/day for 3-6 months. Evaluation of...

Read More

Macular Dilemas in Retinitis Pigmentosa

Advantages: Retinitis pigmentosa is inherited, progressive disease. There is no approved therapy for the disorder itself and there is no approved therapy for its complications as well. Although we are not able to treat RP itself, many secondary changes like cataract, macular edema, macular holes and ERM influencing patientsā€™ vision could be addressed. Methods: Case series to present to diagnostic and treatment challenges in patients...

Read More

Cystoid Macular Edema in Retinitis Pigmentosa

Advantages: To report on medical and surgical treatment for retinitis pigmentosa-associated cystoid macular edema (CME). Retinitis pigmentosa is a progressive inherited retinal disease and one of the main causes of acquired blindness in developed countries. There is no approved therapy able to stop the degeneration of the photorecptor cells and the retinal pigment epithelium. The current management using medical and surgical therapy...

Read More

Chronic Retinal Chip Implant in Blind Patients with Retinitis Pigmentosa

http://www.evrs.eu/medias/2006/congress/Chronic-Retinal-Chip-Implant-in-Blind-Patients-with-Retinitis-Pigmentosa.swf Gisbert Richard, MD (Hamburg, Germany), Michaela Velikay Parel, MD (Graz, Austria), Ralf Hornig, MD (Bonn, Germany), Matthias Feucht, MD (Hamburg, Germany) PURPOSE: To evaluate the performance of an investigational Retinal Implant System in blind patients with retinitis pigmentosa. Objectives of the study are also to test the...

Read More

Evaluation of the Artificial Silicon RetinaTM Device for the Treatment of Vision Loss from Retinitis Pigmentosa

http://www.evrs.eu/medias/2006/congress/Evaluation-of-the-Artificial-Silicon-RetinaTM-Device-for-the-Treatment-of-Vision-Loss-from-Retinitis-Pigmentosa.swf John S. Pollack, MD (Joliet, IL),* Kirk H. Packo, MD (Chicago, IL),* Gislin Dagnelie, PhD (Baltimore, MD), Ron A. Schuchard, PhD (Atlanta, GA), Julia A. Haller, MD (Baltimore, MD), Thomas M. Aaberg, MD (Atlanta, GA), Mathew W. MacCumber, MD, PhD (Chicago, IL), Pauline T. Merrill, MD (Oak...

Read More

Neuroprotective Effects of Sustained-release Intravitreal Fluocinolone Acetonide in RCS Rats

Raymond Iezzi, MD (Detroit, MI), Inna Glybina, MD, PhD (Detroit, MI), Paul Ashton, PhD (Watertown, MA),* Gary W. Abrams, MD (Detroit, MI) PURPOSE: Corticosteroids and estrogens have been shown to exibit neuroprotective effects, mediated via the stabilization of lipid membranes and the inhibition of apoptosis. The purpose of this study was to determine if chronic intravitreal delivery of the synthetic corticosteroid, Fluocinolone Acetonide...

Read More
content top